BALZANO, NUNZIA
 Distribuzione geografica
Continente #
EU - Europa 372
AS - Asia 161
NA - Nord America 82
SA - Sud America 20
AF - Africa 3
Totale 638
Nazione #
RU - Federazione Russa 287
US - Stati Uniti d'America 76
SG - Singapore 60
CN - Cina 41
IT - Italia 41
VN - Vietnam 21
BR - Brasile 14
HK - Hong Kong 11
GB - Regno Unito 10
KR - Corea 8
NL - Olanda 7
AT - Austria 6
FR - Francia 6
IN - India 6
IE - Irlanda 5
MX - Messico 5
DE - Germania 4
JP - Giappone 4
BD - Bangladesh 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
SE - Svezia 2
VE - Venezuela 2
AL - Albania 1
AR - Argentina 1
BH - Bahrain 1
BO - Bolivia 1
CA - Canada 1
CO - Colombia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
ES - Italia 1
FI - Finlandia 1
KE - Kenya 1
MA - Marocco 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 638
Città #
Moscow 99
San Jose 32
Singapore 29
Hefei 15
Naples 13
Ashburn 11
Hong Kong 11
Santa Clara 9
Seoul 8
Amsterdam 7
Ho Chi Minh City 7
Hanoi 6
Bengaluru 5
Dublin 4
Haiphong 4
Afragola 3
Beckenham 3
Beijing 3
Lahore 3
Mexico City 3
Aversa 2
Caivano 2
Council Bluffs 2
London 2
New York 2
Nottingham 2
Pescara 2
Stockholm 2
Vienna 2
Viterbo 2
Ahome 1
Arroio Grande 1
Balneário Camboriú 1
Barra de Guabiraba 1
Bay Shore 1
Bogotá 1
Cachoeiras de Macacu 1
Casablanca 1
Chicago 1
City of London 1
Dallas 1
Dhaka 1
Doutor Camargo 1
Fisciano 1
Frankfurt am Main 1
Go Vap 1
Helsinki 1
Hải Dương 1
Isidro Casanova 1
Johannesburg 1
Juína Municipality 1
La Paz 1
Lençóis Paulista 1
Long Xuyen 1
Madrid 1
Manama 1
Manaus 1
Manchester 1
Maracaibo 1
Marseille 1
Montreal 1
Nairobi 1
New Delhi 1
Newark 1
Nuremberg 1
Orem 1
Passo Fundo 1
Piracicaba 1
Prague 1
Queimados 1
Quito 1
Richmond 1
Riyadh 1
Rome 1
Salerno 1
Sharjah 1
São José do Rio Preto 1
São Luís 1
São Paulo 1
Tirana 1
Valencia 1
Zapopan 1
Ấp Tháp Mười 1
Totale 348
Nome #
Hypogammaglobulinemia in patients with multiple sclerosis receiving disease modifying therapies: disproportionality analysis using the EudraVigilance database 127
Real-World Safety Data of the Orphan Drug Onasemnogene Abeparvovec (Zolgensma®) for the SMA Rare Disease: A Pharmacovigilance Study Based on the EMA Adverse Event Reporting System 116
T-cell malignancies following CAR T-Cell therapy: insights from the FDA Adverse Event Reporting System (FAERS) 115
Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data 113
Risk of Rhabdomyolysis Associated with Dexmedetomidine Use over the Past 10 Years: Insights from the EudraVigilance Database 111
Cardioprotective mechanism of ω-3 fatty acid icosapent ethyl (IPE) in cardiomyocytes: role in high glucose and shear stress-induced mechano-transduction dysregulation 49
Age-related adiponectin resistance in human skeletal muscle dysfunction: in vivo and in vitro evidence 9
Pharmacovigilance study on the reporting frequency of atrial fibrillation with immune checkpoint inhibitors: insights from FDA Adverse Event Reporting System 8
Totale 648
Categoria #
all - tutte 1.333
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.333


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202572 0 0 2 0 12 9 5 4 11 4 13 12
2025/2026576 34 38 28 20 46 289 25 37 30 29 0 0
Totale 648